Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is it time to modify the reverse cholesterol transport model?

A R Tall1, N Wang, P Mucksavage

  • 1Columbia University, Department of Medicine, Division of Molecular Medicine, New York, New York 10032, USA. art1@columbia.edu

The Journal of Clinical Investigation
|November 7, 2001
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins.

Journal of internal medicine·2008
Same author

A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly.

Journal of lipid research·2004
Same author

Haplotypes of the cholesteryl ester transfer protein gene predict lipid-modifying response to statin therapy.

The pharmacogenomics journal·2003
Same author

Acid sphingomyelinase-deficient macrophages have defective cholesterol trafficking and efflux.

The Journal of biological chemistry·2001
Same author

Therapeutic modulation of cellular cholesterol efflux.

Current atherosclerosis reports·2001
Same author

The cellular biology of scavenger receptor class B type I.

Current opinion in lipidology·2001